Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients
VAN TELLINGEN, O, HUIZING, M. T, PANDAY, V. R. N, SCHELLENS, J. H. M, NOOIJEN, W. J, BEIJNEN, J. H
Published in British Journal of Cancer (27.08.1999)
Published in British Journal of Cancer (27.08.1999)
Get full text
Journal Article
Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients
van Tellingen, O, Huizing, M T, Panday, V R, Schellens, J H, Nooijen, W J, Beijnen, J H
Published in British journal of cancer (01.09.1999)
Published in British journal of cancer (01.09.1999)
Get full text
Journal Article
Phase I and Pharmacologic Study of the Combination of Paclitaxel, Cisplatin, and Topotecan Administered Intravenously Every 21 Days as First-Line Therapy in Patients With Advanced Ovarian Cancer
HERBEN, V. M. M, NANNAN PANDAY, V. R, TEN BOKKEL HUININK, W. W, RICHEL, D. J, SCHELLENS, J. H. M, VAN DER VANGE, N, ROSING, H, BEUSENBERG, F. D, HEARN, S, DOYLE, E, BEIJNEN, J. H
Published in Journal of clinical oncology (01.03.1999)
Published in Journal of clinical oncology (01.03.1999)
Get full text
Journal Article
Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma : drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor : A case report study
NANNAN PANDAY, V. R, HOETELMANS, R. M. W, VAN HEESWIJK, R. P. G, MEENHORST, P. L, INGHELS, M, MULDER, J. W, BEIJNEN, J. H
Published in Cancer chemotherapy and pharmacology (1999)
Published in Cancer chemotherapy and pharmacology (1999)
Get full text
Journal Article
A limited-sampling model for the pharmacokinetics of carboplatin administered in combination with paclitaxel
NANNAN PANDAY, V. R, VAN WARMERDAM, L. J. C, HUIZING, M. T, TEN BOKKEL HUININK, W. W, SCHELLENS, J. H. M, BEIJNEN, J. H
Published in Journal of cancer research and clinical oncology (01.11.1999)
Published in Journal of cancer research and clinical oncology (01.11.1999)
Get full text
Journal Article
A single 24-hour plasma sample does not predict the carboplatin AUC from carboplatin-paclitaxel combinations or from a high-dose carboplatin-thiotepa-cyclophosphamide regimen
NANNAN PANDAY, V. R, VAN WARMERDAM, L. J. C, HUIZING, M. T, RODENHUIS, S, SCHELLENS, J. H. M, BEIJNEN, J. H
Published in Cancer chemotherapy and pharmacology (1999)
Published in Cancer chemotherapy and pharmacology (1999)
Get full text
Journal Article
PHARMACOKINETICS OF PACLITAXEL ADMINISTERED AS A 3-HOUR OR 96-HOUR INFUSION
PANDAY, VINODH R.NANNAN, HUININK, WIM W.TEN BOKKEL, VERMORKEN, JAN B., ROSING, HILDE, KOOPMAN, FRANCISCA J., SWART, MARTHA, SCHELLENS, JAN H.M., BEIJNEN, JOS H.
Published in Pharmacological research (01.07.1999)
Published in Pharmacological research (01.07.1999)
Get full text
Journal Article
Pharmacologic study of 3-hour 135 mg M-2 paclitaxel in platinum pretreated patients with advanced ovarian cancer
Panday, V R, Huizing, M T, van Warmerdam, L J, Dubbelman, R C, Mandjes, I, Schellens, J H, Huinink, W W, Beijnen, J H
Published in Pharmacological research (01.09.1998)
Get full text
Published in Pharmacological research (01.09.1998)
Journal Article
Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol) and carboplatin in non-small cell lung cancer patients
Meerum Terwogt, J, van Tellingen, O, Nannan Panday, V R, Huizing, M T, Schellens, J H, ten Bokkel Huinink, W W, Boschma, M U, Giaccone, G, Veenhof, C H, Beijnen, J H
Published in Anti-cancer drugs (01.10.2000)
Published in Anti-cancer drugs (01.10.2000)
Get more information
Journal Article
Pharmacologic study of paclitaxel administered with or without the cytoprotective agent amifostine, and given as a single agent or in combination with epirubicin and cisplatin in patients with advanced solid tumors
Van den Brande, J, Nannan Panday, V R, Hoekman, K, Rosing, H, Huijskes, R V, Verheijen, R H, Beijnen, J H, Vermorken, J B
Published in American journal of clinical oncology (01.08.2001)
Published in American journal of clinical oncology (01.08.2001)
Get more information
Journal Article
Pharmacokinetics of paclitaxel administered in combination with cisplatin, etoposide and bleomycin in patients with advanced solid tumours
NANNANPANDAY, V. R, DE WIT, R, SCHORNAGEL, J. H, SCHOT, M, ROSING, H, LIEVERST, J, TEN BOKKEL HUININK, W. W, SCHELLENS, J. H. M, BEIJNEN, J. H
Published in Cancer chemotherapy and pharmacology (1999)
Published in Cancer chemotherapy and pharmacology (1999)
Get full text
Journal Article
Phase I and pharmacologic study of weekly doxorubicin and 1 h infusional paclitaxel in patients with advanced breast cancer
Panday, V R, ten Bokkel Huinink, W W, Rosing, H, Koopman, F J, Hillebrand, M J, Dubbelman, R C, van Tellingen, O, Schellens, J H, Beijnen, J H
Published in Anti-cancer drugs (01.09.1998)
Published in Anti-cancer drugs (01.09.1998)
Get more information
Journal Article
Primary leiomyosarcoma of the heart presenting as obstruction to the pulmonary trunk
Panday, V.Rajan Nannan, Cramer, Maarten-Jan M., Elbers, Hans R.J., de la Riviere, Aart Brutel, Ernst, Sjef M.P.G., Plokker, H.W.Thijs
Published in The American heart journal (01.04.1997)
Published in The American heart journal (01.04.1997)
Get full text
Journal Article
Carboplatin dosage formulae can generate inaccurate predictions of Carboplatin exposure in carboplatin/paclitaxel combination regimens
Nannan Panday, V R, van Warmerdam, L J, Huizing, M T, Ten Bokkel Huinink, W W, Vermorken, J B, Giaccone, G, Veenhof, C H, Schellens, J H, Beijnen, J H
Published in Clinical drug investigation (1998)
Published in Clinical drug investigation (1998)
Get full text
Journal Article